Background: European treatment guidelines for pTa and pT1 urinary bladder urothelial carcinoma depend highly on stage and WHO-grade. Both the WHO73 and the WHO04 grading systems show some intra- and interobserver variability. The current pilot study investigates which histopathological features are especially sensitive for this undesired lack of reproducibility and the influence on prognostic value. Methods: Thirty-eight cases of primary non-muscle invasive urothelial carcinomas, including thirteen cases with stage progression, were reviewed by three pathologists. Thirteen microscopic features were extracted from pathology textbooks and evaluated separately. Reproducibility was measured using Gwet’s agreement coefficients. Prognostic abilit...
Objectives. This study assessed the diagnostic agreement and intra- and inter-observer reproducibili...
Objectives To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 clas...
Background: Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) i...
Background: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highl...
BACKGROUND: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highl...
Background: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highl...
Two classifications for bladder cancer grade are widely used; the World Health Organization (WHO) 19...
BACKGROUND: Histologic grade is the most important predictor of the clinical outcome of non-muscle i...
Bladder cancer is a common type of cancer, especially among men in developed countries. Most cancers...
BACKGROUND: Grading of noninvasive papillary urinary bladder carcinoma (PUC) is routinely performed ...
Purpose: Histological grade is an important prognostic factor in patients with non-muscle–invasive b...
Objectives: The Royal College of Pathologists minimum dataset recommends the concurrent use of both ...
Objectives. To investigate the relation of the World Health Organization/International Society of Ur...
Background: A new grading system for bladder cancer (BCa) was adopted in 2004 to reduce observer var...
WOS: 000186979700004PubMed ID: 14534785Objectives. This study assessed the diagnostic agreement and ...
Objectives. This study assessed the diagnostic agreement and intra- and inter-observer reproducibili...
Objectives To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 clas...
Background: Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) i...
Background: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highl...
BACKGROUND: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highl...
Background: European treatment guidelines of TaT1 urinary bladder urothelial carcinomas depend highl...
Two classifications for bladder cancer grade are widely used; the World Health Organization (WHO) 19...
BACKGROUND: Histologic grade is the most important predictor of the clinical outcome of non-muscle i...
Bladder cancer is a common type of cancer, especially among men in developed countries. Most cancers...
BACKGROUND: Grading of noninvasive papillary urinary bladder carcinoma (PUC) is routinely performed ...
Purpose: Histological grade is an important prognostic factor in patients with non-muscle–invasive b...
Objectives: The Royal College of Pathologists minimum dataset recommends the concurrent use of both ...
Objectives. To investigate the relation of the World Health Organization/International Society of Ur...
Background: A new grading system for bladder cancer (BCa) was adopted in 2004 to reduce observer var...
WOS: 000186979700004PubMed ID: 14534785Objectives. This study assessed the diagnostic agreement and ...
Objectives. This study assessed the diagnostic agreement and intra- and inter-observer reproducibili...
Objectives To compare the prognostic value of the World Health Organization (WHO) 1973 and 2004 clas...
Background: Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) i...